Speaker: Dr Tony Simula, Program Manager, Research & Development, Cell Therapy Manufacturing CRC, University of South Australia
Title: Managing the manufacturing costs of cell-based therapies – A tale of three surfaces
Chair: Dr Mark DeNichilo, Breast Cancer Research Unit, University of Adelaide and Basil Hetzel Institute, TQEH. Located Level 1, BHI.
Speaker biography: Tony Simula is the Program Manager for the Cell Therapy Manufacturing CRC. He oversees the centre’s research program to ensure the smooth transition of project outcomes into the clinic. He is pivotal to identifying new centre IP of commercial interest to the cell therapy industry and in seeking collaborative and/or licensing opportunities for the centre. Tony has over 20 years experience in the biopharma and cell therapy industries, having been responsible for a number of product development programs, with experience in product management and technical sales support.